BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Janssen R&D Release: Daratumumab Combination Therapy Improved Clinical Outcomes Regardless Of Cytogenetic Risk For Previously-Treated Patients With Multiple Myeloma

  June 5, 2017

   · 

  19 min read
• Drug Development

  Aridis Pharma Presents Positive Phase IIa Safety And Efficacy Data Of Salvecin (AR-301) In Patients With Severe Pneumonia Caused By Staphylococcus Aureus During The 2017 ASM Microbe Congress

  June 5, 2017

   · 

  3 min read
• BioCad Registered The First Rituximab Biosimilar In Bolivia And Honduras

  June 5, 2017

   · 

  1 min read
• Drug Development

  Astellas And Seattle Genetics Announce Updated Enfortumab Vedotin Phase I Data In Metastatic Urothelial Cancer At 2017 ASCO Annual Meeting

  June 5, 2017

   · 

  9 min read
• Calcivis Completes Patient Recruitment Of PMA Clinical Study Evaluating Its Unique CALCIVIS Imaging System

  June 5, 2017

   · 

  3 min read
• Drug Development

  Bristol-Myers Squibb Release: First Presentation Of Efficacy Data From Checkmate -204 Evaluating The Combination Of Opdivo (Nivolumab) And Yervoy (Ipilimumab)Demonstrates Anti-Tumor Activity In Advanced Melanoma Patients With Brain Metastases

  June 5, 2017

   · 

  11 min read
• Drug Development

  NewLink Genetics Release: Results From Clinical Trial Of Indoximod Plus Chemotherapy For Patients With Metastatic Breast Cancer

  June 5, 2017

   · 

  3 min read
• BioMidwest

  Myriad Genetics Announces 17 Additional Health Insurance Plans Covering EndoPredict

  June 5, 2017

   · 

  6 min read
• BioMidwest

  NantWorks Release: NantOmics To Present Clinical Trial Data On The Characterization Of Molecular Profiles Of Metastatic Triple Negative Breast Cancer With GPS Cancer™ At ASCO 2017 Annual Meeting

  June 5, 2017

   · 

  5 min read
• Drug Development

  Celltrion Healthcare Biosimilar Trastuzumab Candidate, CT-P6, Shown To Be Similar In Efficacy And Safety To The Reference Trastuzumab

  June 5, 2017

   · 

  4 min read